Abstract:Ordered mesoporous carbon is a kind of novel carrier for intracellular drug release. There are few reports on the use of mesoporous carbon nanospheres (MCNs) as the transmembrane deliverer in human cancer cells; on the other hand, the particle size of MCNs synthesized by hard templates is usually larger than 100 nm. It is accepted that the optimal size of a transmembrane delivery vehicle should be less than 100 nm in diameter and the surface should be hydrophilic to circumvent clearance by macrophages, to maximize circulation times and targeting ability. In this work, MCNs with a diameter of ca. 90 nm have been developed as a targeted drug delivery system of an anticancer drug, doxorubicin (DOX). The small MCNs were synthesized using triblock copolymer Pluronic F127 as a template. The MCNs were first treated by acid to improve its dispersion property in an aqueous solution, and then modified by folic acid through EDC-NHS. The structure of the MCNs was well characterized by transmission electron microscopy, small-angle X-ray scattering, nitrogen adsorption/desorption and dynamic light scattering, pH-dependent drug release is successfully achieved due to the supramolecular pi-pi stacking between DOX and the carbonaceous structures. By effective passive and active targeting, MCNs can be readily internalized into HeLa cells, where the carried DOX can be efficiently released in the acidic microenvironment of the tumors for further therapy. The results from confocal laser scanning microscope and flow cytometry demonstrated that the cellular uptake efficiency of MCNs toward HeLa cells was increased through the functionalization with folic acid, and the folate modified MCNs show much higher endocytosis properties toward HeLa cells (folate receptor positive) than toward MCF-7 cells (folate receptor negative). The cytotoxicities toward HeLa cells were studied by MTT method, which indicated that the cytotoxicities of DOX loaded mesoporous carbon nanoparticles was also enhanced due to the introduction of folic acid and targeted delivery, while the cytotoxicities of MCNs show very good biocompatibility toward both HeLa and KB cells.

Hydrophilic Mesoporous Carbon Nanoparticles As Carriers for Sustained Release of Hydrophobic Anti-Cancer Drugs

In Situ Protein-Templated Porous Protein-Hydroxylapatite Nanocomposite Microspheres for Ph-Dependent Sustained Anticancer Drug Release

Tlyp-1-conjugated Mesoporous Silica Nanoparticles for Tumor Targeting and Penetrating Hydrophobic Drug Delivery

One-Step Synthesis of Nitrogen-Doped Hydrophilic Mesoporous Carbons from Chitosan-Based Triconstituent System for Drug Release

Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs

Mesoporous NiS2 Nanospheres As a Hydrophobic Anticancer Drug Delivery Vehicle for Synergistic Photothermal-Chemotherapy

Injectable hydrogel imbibed with camptothecin-loaded mesoporous silica nanoparticles as an implantable sustained delivery depot for cancer therapy

Dual Responsive Mesoporous Silica Nanoparticles for Targeted Co-Delivery of Hydrophobic and Hydrophilic Anticancer Drugs to Tumor Cells.

Chitosan-based Nanocarriers with Ph and Light Dual Response for Anticancer Drug Delivery.

Folate Functionalized Mesoporous Carbon Nanospheres As Nanocarrier for Targetted Delivery and Controlled Release of Doxorubicin to HeLa Cells

Gated Mesoporous Carbon Nanoparticles As Drug Delivery System for Stimuli-Responsive Controlled Release

Nanomicelle Based Peroral Delivery System for Enhanced Absorption and Sustained Release of 10-Hydrocamptothecin

In Situ Encapsulation of Camptothecin by Self-Assembly of Poly(acrylic acid)-b-Poly(N-Isopropylacrylamide) and Chitosan for Controlled Drug Delivery

pH-responsive polyacrylic acid (PAA)-carboxymethyl cellulose (CMC) hydrogel incorporating halloysite nanotubes (HNT) for controlled curcumin delivery

β-Cyclodextrin-based supramolecular nanoparticles: a pH-sensitive nanocarrier for the sustained release of the anti-tumor drug

Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells.

Walnut kernel-like mesoporous silica nanoparticles as effective drug carrier for cancer therapy in vitro

Oxidation modification of chitosan-based mesoporous carbon by soft template method and the adsorption and release properties of hydroxycamptothecin

pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres.

pH-responsive materials based on sodium carboxymethyl cellulose as a safe and effective strategy for camptothecin delivery

Calcium carbonate microspheres as carriers for the anticancer drug camptothecin